SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-23-094106
Filing Date
2023-12-07
Accepted
2023-12-07 17:03:16
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea189612-s3_biomxinc.htm S-3 411281
2 AT THE MARKET OFFERING AGREEMENT, DATED DECEMBER 7, 2023, BETWEEN THE COMPANY AN ea189612ex1-2_biomxinc.htm EX-1.2 217145
3 OPINION OF SULLIVAN & WORCESTER LLP ea189612ex5-1_biomxinc.htm EX-5.1 18918
4 CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A MEMBER ea189612ex23-1_biomxinc.htm EX-23.1 2223
5 FILING FEE TABLE ea189612ex-fee_biomxinc.htm EX-FILING FEES 108156
6 GRAPHIC image_001.jpg GRAPHIC 3716
7 GRAPHIC ex5-1_001.jpg GRAPHIC 31652
8 GRAPHIC ex5-1_002.jpg GRAPHIC 9173
  Complete submission text file 0001213900-23-094106.txt   820543
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275935 | Film No.: 231473048
SIC: 2836 Biological Products, (No Diagnostic Substances)